OCEL
OCEL company profile
Latest price
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
3 articles
Price performance
Recent trading
Newsroom
Latest OCEL coverage
Organicell Starts Enrolling Long COVID Trial
Organicell Regenerative Medicine, Inc. (OTCQB: OCEL), is pleased to announce that the long COVID Clinical Trial is officially active with enrollment.
Organicell Activates COPD Trial at Mayo Clinic
DAVIE, FL / ACCESSWIRE / November 15, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB: OCEL), is pleased to announce that Mayo Clinic will be the site for clinical trials on Chronic Obstructive Pulmonary Disease (COPD).
Organicell Regenerative Medicine, Inc. Engages law firm McDermott Will & Emery
MIAMI, FL / ACCESSWIRE / August 30, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focused on the development of innovative regenerative medicine and biological therapeutics, announced today the broad-based engagement of top international law firm McDermott Will & Emery, widely considered to